PMFA
LCTX icon

Plante Moran Financial Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Plante Moran Financial Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$1 – 901
2024
Q4 		$1 Hold
2
– – ﹤0.01% 903
2024
Q3 		$2 Hold
2
– – ﹤0.01% 870
2024
Q2 		$2 Hold
2
– – ﹤0.01% 785
2024
Q1 		$3 Hold
2
– – ﹤0.01% 839
2023
Q4 		$2 Buy
+2
New +$2 ﹤0.01% 817
2013
Q3 		– Sell
-6,195
Closed -$20K – 653
2013
Q2 		$20K Buy
+6,195
New +$19.8K 0.01% 248

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return